News
Arthrosi Therapeutics receives FDA Fast Track approval for AR882 in topose gout
SAN DIEGO, 19 August 2024 /PRNewswire/ — Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially first-in-class, highly potent
3 Minute